Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Silicon Group has demonstrated that its LightSense™ biosensor can rapidly, sensitively, and cost-effectively measure multiple proteins simultaneously. The company’s technology is being validated through collaborations with industry partners such as Axogen for nerve tissue growth applications and has received recognition from DARPA ERIS Marketplace as "Awardable." It has also secured several SBIR/STTR grants to further develop its platform for both healthcare diagnostics and bioprocess monitoring.[1][3][4][6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Silicon Group.